NCT00499824 GIANT: General Practitioner Implementation in Asia of Normoglycaemic Targets Status COMPLETED Phase NA
NCT00497133 Alpha-Cell Sensitivity to GLP-1 in Patients With Type 2 Diabetes Status COMPLETED Phase N/A
NCT00495014 Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects Status COMPLETED Phase PHASE1
NCT00486291 Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese Diabetics Status COMPLETED Phase PHASE2
NCT00486187 Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study Status COMPLETED Phase NA
NCT00482950 A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus Status UNKNOWN Phase PHASE2
NCT00482729 MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00482183 Comparison Between Pioglitazone and SES With type2 DM Status COMPLETED Phase PHASE2/PHASE3
NCT00479986 Effects of Pioglitazone in Type 2 Diabetes Mellitus and Coronary Heart Disease Status COMPLETED Phase PHASE4
NCT00479791 Lipid, Glycemic, and Insulin Responses to Meals Rich in Different Fatty Acids Status COMPLETED Phase NA
NCT00477581 A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT00474838 Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin Therapy Status COMPLETED Phase PHASE4
NCT00467649 A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00467168 Optimal Dietary Fat Pattern to Prevent Cardiovascular Disease Among Type 2 Diabetes Status COMPLETED Phase PHASE1/PHASE2
NCT00458016 Safety, Tolerability, and Efficacy Study of MB07803 Administered to Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT00455598 Placebo Controlled, Dose Escalation Study in Subjects With Type 2 Diabetes Mellitus Being Treated With Sulfonylurea Status COMPLETED Phase PHASE2